Internal Medicine, Endocrinology, Diabetes, & Metabolism · Bayamon, PR
NPI
1194187336
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
Bayamon Health Center, Calle Manuel D. Rossi, Segundo Nivel
Bayamon, PR, 00961
Phone (787) 269-6590
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,350
35 services
Medicare patients, 2024
16
Average age 70
Drug cost, 2024
$2.4M
5,676 prescriptions
Company payments, 2025
$147
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Amelia C Guzman-Bicchi prescribed most often to Medicare patients was Ozempic (Semaglutide), with 845 prescriptions and refills. In total Amelia C Guzman-Bicchi wrote 5,676 Medicare prescriptions that cost $2.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 845 | 858 | 129 | $835K |
| Synthroid Levothyroxine Sodium | 651 | 1,123 | 158 | $54K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 366 | 384 | 60 | $233K |
| Trulicity Dulaglutide | 310 | 326 | 55 | $322K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 265 | 359 | 60 | $27K |
| Metformin Hcl Generic | 262 | 404 | 70 | $1,581 |
| Mounjaro Tirzepatide | 207 | 209 | 31 | $225K |
| Glipizide Generic | 195 | 319 | 58 | $3,030 |
| Rosuvastatin Calcium Generic | 175 | 337 | 50 | $2,059 |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 172 | 210 | 34 | $128K |
| Jardiance Empagliflozin | 167 | 183 | 37 | $113K |
| Atorvastatin Calcium Generic | 159 | 309 | 46 | $1,600 |
| Glimepiride Generic | 128 | 176 | 29 | $1,997 |
| Farxiga Dapagliflozin Propanediol | 111 | 139 | 26 | $81K |
| Jentadueto Xr Linagliptin/Metformin Hcl | 101 | 111 | 25 | $59K |
Brand drugs: 3,809 claims; generic drugs: 1,652 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amelia C Guzman-Bicchi $147 ($147 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $122.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.